Skip to main content
. Author manuscript; available in PMC: 2011 Oct 15.
Published in final edited form as: J Infect Dis. 2010 Oct 15;202(Suppl 2):S315–S322. doi: 10.1086/655654

Figure 2.

Figure 2

Antibodies act as a bridge that can provide specificity and therefore focus the antiviral activity of innate immune cells to eliminate or contain viral replication following an interaction with an Fc-receptor located on the surface of an innate immune effector cell (including monocytes, NK cells, DCs, neutrophils, and other granulocytes).